Munafa Stock Market Course + Intraday & FNO calls 
Sonoma Pharmaceuticals (SNOA) Technical (Analysis) Reports Sonoma Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Sonoma Pharmaceuticals (SNOA)
Technical Analysis Report for USA stock SNOA Sonoma Pharmaceuticals. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock SNOA Sonoma Pharmaceuticals then click here. or read Experts views on Sonoma Pharmaceuticals or Forecast & share price targets of Sonoma Pharmaceuticals
Sonoma Pharmaceuticals Opened at 3.00 and Closed at: 3.03, which is -0.99% of previous session's close. It moved within a range of 2.91 and 3.16
The session was a Bullish session with an average volume of 17200, which is -5.23% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
Support for tomorrow is 2.97 and resistance for tomorrow is 3.22
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 2.91, 2.78 resistance for tomorrow's hourly charts is 3.16, 3.28
10 Day SMA for Sonoma Pharmaceuticals (SNOA) is 3.26 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Sonoma Pharmaceuticals (SNOA) is 3.31 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Sonoma Pharmaceuticals (SNOA) is 3.45 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 3.66 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Sonoma Pharmaceuticals is 3.63 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Sonoma Pharmaceuticals is at 3.31 and 200 DMA is at 3.63, while 50 DMA and 100 DMA are at 3.45 and 3.66 respectively
Sonoma Pharmaceuticals (SNOA) moving average of 20 SMA is at 3.31 and 20 EMA is at 3.3
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 3.03 | 3.31 | 3.3 |
| 05 Thu Feb | 3.06 | 3.35 | 3.33 |
| 04 Wed Feb | 3.20 | 3.39 | 3.36 |
| 03 Tue Feb | 3.23 | 3.42 | 3.38 |
| 02 Mon Feb | 3.21 | 3.44 | 3.4 |
| 30 Fri Jan | 3.28 | 3.46 | 3.42 |
Sonoma Pharmaceuticals (SNOA) moving average of 50 SMA is at 3.45 and 50 EMA is at 3.45
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 3.03 | 3.45 | 3.45 |
| 05 Thu Feb | 3.06 | 3.45 | 3.47 |
| 04 Wed Feb | 3.20 | 3.46 | 3.49 |
| 03 Tue Feb | 3.23 | 3.46 | 3.5 |
| 02 Mon Feb | 3.21 | 3.46 | 3.51 |
| 30 Fri Jan | 3.28 | 3.47 | 3.52 |
Sonoma Pharmaceuticals (SNOA) moving average of 100 SMA is at 3.66 and 100 EMA is at 3.55
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 3.03 | 3.66 | 3.55 |
| 05 Thu Feb | 3.06 | 3.68 | 3.56 |
| 04 Wed Feb | 3.20 | 3.69 | 3.57 |
| 03 Tue Feb | 3.23 | 3.7 | 3.58 |
| 02 Mon Feb | 3.21 | 3.72 | 3.59 |
| 30 Fri Jan | 3.28 | 3.73 | 3.6 |
Sonoma Pharmaceuticals (SNOA) moving average of 200 SMA is at 3.63 and 200 EMA is at 3.45
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 3.03 | 3.63 | 3.45 |
| 05 Thu Feb | 3.06 | 3.63 | 3.45 |
| 04 Wed Feb | 3.20 | 3.62 | 3.45 |
| 03 Tue Feb | 3.23 | 3.62 | 3.45 |
| 02 Mon Feb | 3.21 | 3.62 | 3.45 |
| 30 Fri Jan | 3.28 | 3.61 | 3.45 |
Zoetis Inc has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Zoetis Inc, about 17.19% more returns!
Glaxosmithkline Plc has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Glaxosmithkline Plc, about 36.52% more returns!
Community Health has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Community Health, about 11.87% more returns!
Sonoma Pharmaceuticals has performed better than Centene Corporation in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Chemed Corp has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Chemed Corp, about 17.74% more returns!
Brookdale Senior has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Brookdale Senior, about 63.22% more returns!
Xtl Biopharmaceuticals has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Xtl Biopharmaceuticals, about 76.69% more returns!
Vistagen Therapeutics has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Vistagen Therapeutics, about 1.84% more returns!
Sellas Life has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Sellas Life, about 24.17% more returns!
Sonoma Pharmaceuticals has performed better than Sintx Technologies in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Proqr Therapeutics has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Proqr Therapeutics, about 1.74% more returns!
Organogenesis Holdings has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Organogenesis Holdings, about 6.54% more returns!
Natera Inc has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Natera Inc, about 3.64% more returns!
Seres Therapeutics has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Seres Therapeutics, about 6.19% more returns!
Ionis Pharmaceuticals has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Ionis Pharmaceuticals, about 24.71% more returns!
Sonoma Pharmaceuticals has performed better than Inogen Inc in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Sonoma Pharmaceuticals has performed better than Integra Lifesciences in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Genprex Inc has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Genprex Inc, about 16.99% more returns!
Sonoma Pharmaceuticals has performed better than Alphatec Holdings in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Sonoma Pharmaceuticals Technical analysis of indicators
Price action analysis of Sonoma Pharmaceuticals (SNOA) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Sonoma Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Sonoma Pharmaceuticals in short term and the sell signal is strong.
Sonoma Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Sonoma Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Sonoma Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.21 and Sonoma Pharmaceuticals SNOA stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Sonoma Pharmaceuticals SNOA stock. Volume based technical analysis of Sonoma Pharmaceuticals SNOA stock is negative.
Sonoma Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock SNOA Sonoma Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SNOA Experts View which covers a lot of information including buying and selling signals
SNOA future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Sonoma Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Sonoma Pharmaceuticals (SNOA) Technical (Analysis) Reports Sonoma Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
